Joshua T. Brumm, CEO & President: Dyne Therapeutics DYN Sell · Filed 24/03/12

Trade details

Type: Insider sale
Amount: $4,293,102.4
Shares · price: 160,670 sh · $26.72 a share
Held after: 554,820 sh
Stock: Dyne Therapeutics DYN
Person: Joshua T. BrummCEO & President
Trade date: 24/03/08
Filed: 24/03/12
Days to filing: 4 days

Sold 22.5% of holdings

Share of holding sold: 22.5%

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/07~24/04/07

Joshua T. Brumm's recent trades

Joshua T. BrummCEO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$154.8K
9,013 sh
$154.8K
Filed 09/17
Traded 09/18
Joshua T. BrummCEO
Planned sale10b5-1 planCrescent Biopharma
Planned sale10b5-1 plan
Crescent Biopharma
CBIO
$33.3K
1,771 sh
$33.3K
Filed 09/16
Traded 09/16
Joshua T. BrummCEO
Sell10b5-1 planCrescent Biopharma
Sell10b5-1 plan
Crescent Biopharma
CBIO
$761.1K
42,305 sh
$761.1K
Filed 06/23
Traded 06/22
Joshua T. BrummCEO & President
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$5.1M
202,238 sh
$5.1M
Filed 24/03/12
Traded 24/03/08
Joshua T. BrummCEO & President
Sell10b5-1 planDyne Therapeutics
Sell10b5-1 plan
Dyne Therapeutics
DYN
$1M
40,072 sh
$1M
Filed 24/03/12
Traded 24/03/11

Joshua T. Brumm, CEO — sold $4.3M of Dyne Therapeutics DYN · 22.5% of holdings · 10b5-1 plan | Whalegun